<SEC-DOCUMENT>0001128732-16-000032.txt : 20161107
<SEC-HEADER>0001128732-16-000032.hdr.sgml : 20161107
<ACCEPTANCE-DATETIME>20161107121017
ACCESSION NUMBER:		0001128732-16-000032
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20161010
FILED AS OF DATE:		20161107
DATE AS OF CHANGE:		20161107

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sunshine Biopharma, Inc
		CENTRAL INDEX KEY:			0001402328
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				205566275
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		469 JEAN-TALON WEST
		STREET 2:		3RD FLOOR
		CITY:			MONTREAL
		STATE:			A8
		ZIP:			H3N 1R4
		BUSINESS PHONE:		514-764-9698

	MAIL ADDRESS:	
		STREET 1:		469 JEAN-TALON WEST
		STREET 2:		3RD FLOOR
		CITY:			MONTREAL
		STATE:			A8
		ZIP:			H3N 1R4

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Mountain West Business Solutions, Inc
		DATE OF NAME CHANGE:	20071030

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	mountain west business solutions,inc
		DATE OF NAME CHANGE:	20070607

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Advanomics Corp
		CENTRAL INDEX KEY:			0001681176
		STATE OF INCORPORATION:			A8
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52898
		FILM NUMBER:		161977189

	BUSINESS ADDRESS:	
		STREET 1:		579 RUE LAJEUNESSE
		CITY:			LAVAL
		STATE:			A8
		ZIP:			H7X 3K4
		BUSINESS PHONE:		514-949-6722

	MAIL ADDRESS:	
		STREET 1:		579 RUE LAJEUNESSE
		CITY:			LAVAL
		STATE:			A8
		ZIP:			H7X 3K4
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2016-10-10</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001402328</issuerCik>
        <issuerName>Sunshine Biopharma, Inc</issuerName>
        <issuerTradingSymbol>SBFM</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001681176</rptOwnerCik>
            <rptOwnerName>Advanomics Corp</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>579 RUE LAJEUNESSE</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>LAVAL</rptOwnerCity>
            <rptOwnerState>A8</rptOwnerState>
            <rptOwnerZipCode>H7X 3K4</rptOwnerZipCode>
            <rptOwnerStateDescription>QUEBEC, CANADA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2016-10-10</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>J</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
                <footnoteId id="F1"/>
            </transactionCoding>
            <transactionTimeliness>
                <value></value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>136861968</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                    <footnoteId id="F1"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>215014224</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">136,861,968 shares were disposed of pursuant to a share exchange with an unrelated entity; no consideration was received as a result of the share exchange.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Steve N. Slilaty</signatureName>
        <signatureDate>2016-11-07</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
